Erratum to: Substantia nigra in Parkinson's disease: A multimodal MRI comparison between early and advanced stages of the disease (Neurological Sciences DOI: 10.1007/s10072-013-1595-2);Substantia nigra in Parkinson's disease: A multimodal MRI comparison between early and advanced stages of the disease

Neurological Sciences

Volumn 35, Issue 5, 2014, Pages 753-758

  Aquino, Domenico ^a   Contarino, Valeria ^a   Albanese, Alberto ^a   Minati, Ludovico ^a   Farina, Laura ^a   Grisoli, Marina ^a   Elia, Antonio ^a   Bruzzone, Maria Grazia ^a   Chiapparini, Luisa ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Diffusion tensor imaging; Inversion recovery; Parkinson disease; Relaxometry; Substantia nigra; UPDRS

Indexed keywords

IRON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FRACTIONAL ANISOTROPY; HEALTH STATUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; SUBSTANTIA NIGRA; UNIFIED PARKINSON DISEASE RATING SCALE; ANISOTROPY; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; METABOLISM; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ANISOTROPY; DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION TENSOR IMAGING; DISEASE PROGRESSION; FEMALE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SUBSTANTIA NIGRA;

EID: 84901381999     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-014-1678-8     Document Type: Erratum

References (30)

1. Halliday G, Lees A, Stern M (2011) Milestones in Parkinson's disease - clinical and pathologic features. Mov Disord 26:1015-1021
2. Seppi K, Poewe W (2010) Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes. Neuroimaging Clin N Am 20:29-55
3. Dickson DW, Braak H, Duda JE et al (2009) Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 8:1150-1157
4. Chahine LM, Stern MB (2011) Diagnostic markers for Parkinson's disease. Curr Opin Neurol 24:309-317
5. Wilson JM, Levey AI, Rajput A et al (1996) Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology 47:718-726 (Pubitemid 26307303)
6. Innis RB, Seibyl JP, Scanley BE et al (1993) Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc Natl Acad Sci USA 90:11965-11969 (Pubitemid 24008761)
7. Leenders KL, Oertel WH (2001) Parkinson's disease: clinical signs and symptoms, neural mechanisms, positron emission tomography, and therapeutic interventions. Neural Plast 8:99-110 (Pubitemid 32798691)
8. Thobois S, Jahanshahi M, Pinto S, Frackowiak R, Limousin-Dowsey P (2004) PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences. Neuroimage 23:1-16 (Pubitemid 39119429)
9. Hutchinson M, Raff U (2008) Detection of Parkinson's disease by MRI: spin-lattice distribution imaging. Mov Disord 23:1991-1997
10. Minati L, Grisoli M, Carella F, De Simone T, Bruzzone MG, Savoiardo M (2007) Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging. AJNR Am J Neuroradiol 28:309-313
11. Vaillancourt DE, Spraker MB, Prodoehl J et al (2009) High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 72:1378-1384
12. Sian-Hülsmann J, Mandel S, Youdim MB, Riederer P (2011) The relevance of iron in the pathogenesis of Parkinson's disease. J Neurochem 118(6):939-957
13. Carroll CB, Zeissler ML, Chadborn N et al (2011) Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson's disease. Neurochem Int 59:73-80
14. Martin WR, Wieler M, Gee M (2008) Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70:1411-1417 (Pubitemid 351521933)
15. Péran P, Cherubini A, Assogna F et al (2010) Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 133:3423-3433
16. Cherubini A, Péran P, Caltagirone C, Sabatini U, Spalletta G (2009) Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI. Neuroimage 48:29-36
17. Hutchinson M, Raff U (1999) Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra. J Neurol Neurosurg Psychiatry 69:815-818
18. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184
19. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427-442
20. Brazzelli M, Capitani E, Della Sala S, Spinnler H, Zuffi M (1994) A neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan overall dementia assessment. J Neurol Neurosurg Psychiatry 57:1510-1517
21. Romito LM, Contarino MF, Vanacore N, Bentivoglio AR, Scerrati M, Albanese A (2009) Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation. Mov Disord 24:557-563
22. Fahn S, Elton RL (1987) Members of the UPDRS Development Committee. Unified Parkinsons disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent developments in Parkinsons disease, 2nd edn. Macmillan Healthcare Information, Florham Park, pp 153-163
23. Raff U, Hutchinson M, Rojas GM, Huete I (2006) Inversion recovery MRI in idiopathic Parkinson disease is a very sensitive tool to assess neurodegeneration in the substantia nigra: preliminary investigation. Acad Radiol 13:721-727
24. Basser PJ, Pierpaoli C (1996) Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 111:209-219 (Pubitemid 126758682)
25. Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3:41-51
26. Aquino D, Bizzi A, Grisoli M, Garavaglia B, Bruzzone MG, Nardocci N (2009) Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 252:165-172
27. Gattellaro G, Minati L, Grisoli M, Mariani C, Carella F, Bruzzone MG (2009) White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol 30:1222-1226
28. Du G, Lewis MM, Styner M, Shaffer ML, Sen S, Yang QX, Huang X (2011) Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Mov Disord 26:1627-1632
29. Meijer FJA, Bloem RB, Mahlknecht P, Seppi K, Goraj B (2013) Update on diffusion MRI in Parkinson's disease and atypical parkinsonism. J Neurol Sci 332(2013):21-29
30. Chan LL, Rumpel H, Yap K, Lee E, Loo HV, Ho GL et al (2007) Case control study of diffusion tensor imaging in Parkinson's disease. J Neurol Neurosurg Psychiatry 78(12):1383-1386 (Pubitemid 350221424)